- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04813809
A Clinical Investigation With BARRIER® EasyWarm® (EasyWarm01)
A Prospective, Open, Non-comparative, Single-centre Investigation to Study the Effect of BARRIER® EasyWarm® Active Self-warming Blanket on Skin- and Body Core Temperatures in Healthy Volunteers
Study Overview
Detailed Description
This investigation is a prospective, open, non-comparative, single-center investigation with the aim to investigate the effect of BARRIER EasyWarm active self-warming blanket on skin- and body core temperatures.
The investigation will enroll approximately 20 healthy volunteers in one investigation site. Each subject will be evaluated for up to 10 hours in one visit on site. Body core- and skin reference temperatures will be established before applying the blanket. After reference temperature assessments, the BARRIER EasyWarm is positioned on the subject with the neckline at the collarbone. Skin temperatures will be assessed with an IR camera and body core temperatures will be assessed with an ear thermometer at 30 min, 1 hour, 2, 3, 4, 5, 6, 7, 8, 9, and 10 hours post blanket application. Subject perception of heat from the blanket will be assessed at 30 minutes, 5 hours and 10 hours post blanket application by means of a five graded question.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Gothenburg, Sweden, 41345
- /Sahlgrenska University Hospital/Clinical Trial Center/Gothia Forum
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Provision of informed consent
- Adult males and females ≥ 18 years old
- Able to maintain a supine position up to 10 hours.
Exclusion Criteria:
Diseases/medical treatments that affect normal body temperature control:
I. Persons who have/have had thyroid disease or who are treated with medications affecting the thyroid hormones
II. Persons being treated with medication affecting normal body temperature control, based on investigator judgement.
- Impaired circulation/vascular disease
- Impaired sensitivity/neuropathy
- Active skin disease
- Female with temperature variations due to menopause
- Pregnancy or lactation at time of study participation.
- Person not suitable for the investigation according to the clinician's judgement.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: BARRIER EasyWarm
This is an open, non randomised, single arm study
|
Application of BARRIER EasyWarm for 10 hours.
The treatment with the investigational device will be according to the instruction stated on the investigational device.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Skin temperature
Time Frame: 10 hours
|
Relative change in average skin temperature (ºC)
|
10 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Skin temperature 1
Time Frame: 30 minutes, and 1, 2, 3, 4, 5, 6, 7, 8, 9 hours
|
Relative change in average skin temperature at 30 minutes, and 1, 2, 3, 4, 5, 6, 7, 8 and 9 hours (ºC).
Assessed with an IR camera.
|
30 minutes, and 1, 2, 3, 4, 5, 6, 7, 8, 9 hours
|
Skin temperature 2
Time Frame: 30 minutes, and 1, 2, 3, 4, 5, 6, 7, 8, 9 and10 hours
|
Maximum skin temperature at 30 minutes, and 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 hours (ºC).
Assessed with an IR camera.
|
30 minutes, and 1, 2, 3, 4, 5, 6, 7, 8, 9 and10 hours
|
Skin temperature 3
Time Frame: 30 minutes, and 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 hours
|
Average skin temperature at 30 minutes, and 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 hours (ºC).
Assessed with an IR camera.
|
30 minutes, and 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 hours
|
Body Core Temperature 1
Time Frame: 30 minutes, and 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 hours
|
Body core temperature (ºC) at 30 minutes, and 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 hours.
Assessed with an ear thermometer.
|
30 minutes, and 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 hours
|
Body Core temperature 2
Time Frame: 30 minutes, and 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 hours
|
Relative change in body core temperature (ºC) at 30 minutes, and 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 hours compared to baseline.
Assessed with an ear thermometer.
|
30 minutes, and 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 hours
|
Heat perception
Time Frame: 30 minutes, 5 hours and 10 hours
|
Five-point question related to perception of heat from the BARRIER EasyWarm.
Assessed at 30 minutes, 5 hours and 10 hours post application.
Scale: Cold, cool, not cool or warm, warm, hot.
|
30 minutes, 5 hours and 10 hours
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- EasyWarm01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
PMV Pharmaceuticals, IncRecruitingHealthy VolunteersUnited States
Clinical Trials on BARRIER EasyWarm
-
Molnlycke Health Care ABCompletedInadvertent Perioperative Hypothermia | Anesthesia Induced Hypothermia
-
Molnlycke Health Care ABCompletedInadvertent Perioperative Hypothermia | Preoperative Anxiety Experienced by the PatientGermany, United Kingdom, Norway
-
Aleris HelseCompletedPerioperative/Postoperative ComplicationsNorway
-
Tampere University HospitalCompleted
-
Beijing Tiantan HospitalGuangzhou First People's Hospital; Tang-Du Hospital; Anhui Provincial Hospital; Suzhou Municipal Hospital and other collaboratorsRecruiting
-
Marmara UniversityRecruiting
-
Marmara UniversityCompleted
-
Haukeland University HospitalRecruitingHypothermia, AccidentalNorway
-
The Guthrie ClinicCompleted